IMA stock

ImageneBio, Inc. (IMA) financials · rev $800.0K

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

ImageneBio, Inc. (IMA) rev $800.0K.

Cached annual income statement
LineFY2025FY2024
Revenue$800.0K$3.50M
Operating Income-$48.5M-$59.0M
Net Income-$45.3M-$49.2M
EPS (Diluted)-$9.64-$1.02
Cached annual balance sheet
LineFY2025FY2024
Total Assets$153.0M$141.5M
Current Assets$140.3M$127.2M
Cash & Equivalents$94.5M$39.4M
PP&EN/A$593.0K
Total Liabilities$19.8M$15.6M
Current Liabilities$11.2M$10.8M
Short-term DebtN/A$7.50M
Total DebtN/A$7.50M
Shareholders' Equity$133.1M$125.9M
Retained Earnings-$230.1M-$331.6M

† Total Debt: Derived from short-term debt only (no total or long-term debt stored).

Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$47.8M-$46.0M
Investing Cash Flow-$5.81M-$34.9M
Financing Cash Flow$135.5M$6.91M
Net Change in Cash$82.4M-$3.20M
These statements as JSON? API free 100/day

FAQ

What is IMA P/E and revenue?

ImageneBio, Inc. (IMA) rev $800.0K.

What is IMA revenue?

ImageneBio, Inc. last cached revenue is $800.0K (FY2025).

Is IMA profitable?

ImageneBio, Inc. last cached net income is -$45.3M (FY2025).

What are IMA total assets?

ImageneBio, Inc. last cached total assets are $153.0M (FY2025).

What is IMA free cash flow?

No cached cash-flow row for IMA yet.

Not investment advice. Cached statements, not a live tape.